Comparison of Healthcare Costs Between Rheumatoid Arthritis Patients Treated with Infused Biologics After Switching from Another Biologic

INTRODUCTION: While there is a substantial body of literature on the comparative healthcare costs of biologics used to treat rheumatoid arthritis (RA), nearly all of these investigations have been exclusively focused on anti-tumor necrosis factor-α (anti-TNF) agents in the setting of first-line biol...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnston, Stephen S., McMorrow, Donna, Farr, Amanda M., Juneau, Paul, Ogale, Sarika
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883205/
https://www.ncbi.nlm.nih.gov/pubmed/27747619
http://dx.doi.org/10.1007/s40801-015-0018-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4883205/
https://www.ncbi.nlm.nih.gov/pubmed/27747619
http://dx.doi.org/10.1007/s40801-015-0018-5

Ejemplares similares